Moreover, sporadic AD patient iNs harboring APOE ε3/4 exhibited a significantly higher IGFBP3 expression than that observed in AD patient-derived iN lines with the APOE ε3/3 genotype. This evidence concerns the gene IGFBP3 and Alzheimer disease.